z-logo
open-access-imgOpen Access
Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors
Author(s) -
Jomana Madieh,
Iman Khamayseh,
Alaa Hrizat,
Abdurrahman Hamadah,
Kamel A. Gharaibeh
Publication year - 2021
Publication title -
case reports in nephrology
Language(s) - English
Resource type - Journals
eISSN - 2090-6641
pISSN - 2090-665X
DOI - 10.1155/2021/8862405
Subject(s) - mixed connective tissue disease , polymyositis , scleroderma (fungus) , medicine , dermatomyositis , connective tissue disorder , connective tissue disease , angiotensin converting enzyme , dermatology , autoantibody , connective tissue , disease , pathology , immunology , autoimmune disease , antibody , blood pressure , inoculation
Mixed connective tissue disease (MCTD) is a rheumatic disease syndrome with overlapping features of scleroderma, systemic lupus erythematosus, and polymyositis. An extremely rare but serious complication that can occur in MCTD is scleroderma renal crisis (SRC). There have been different approaches to the treatment of SRC associated with MCTD. We present a case of MCTD with chronic features of Raynaud's phenomenon, dermatomyositis, and thrombocytopenia complicated with acute SRC which showed a great response to ACE inhibitors. Here, we advise the early and aggressive use of ACE inhibitors as soon as SRC is suspected.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom